Elanco Animal Health Inc

詳細情報 Elanco Animal Health Inc 企業名

Elanco Animal Health Incorporated is an animal health company. The Company is focused on delivering products and services to prevent and treat disease in farm animals and pets. Its diverse, durable product portfolio serves animals across many species, primarily: dogs, cats and cattle, poultry, swine, and sheep. It offers products in two primary categories: Pet Health and Farm Animal. Its Pet Health portfolio is focused on parasiticides, vaccines and therapeutics. Its Pet Health portfolio has products that protect pets from fleas, ticks and internal parasites. Its Farm Animal portfolio of products is primarily focused on cattle, swine, and poultry. Its Pet Health products include Advantage Family, Atopica, Claro/ Neptra, Credelio Family, Drontal Family, Galliprant, Interceptor Plus, Milbemax, Onsior, Seresto, Trifexis, and TruCan. Its Farm Animal products include AviPro, Baycox, Catosal, Comforta, Denagard, Experior, Hemicell, Maxiban, Monteban, Pulmotil, Rumensin, and others.

企業情報

企業コードELAN

会社名Elanco Animal Health Inc

上場日Sep 20, 2018

最高経営責任者「CEO」Mr. Jeffrey N. (Jeff) Simmons

従業員数9000

証券種類Ordinary Share

決算期末Sep 20

本社所在地2500 Innovation Way N

都市GREENFIELD

証券取引所NYSE Consolidated

国United States of America

郵便番号46140-9163

電話番号18773526261

ウェブサイトhttps://www.elanco.com/

企業コードELAN

上場日Sep 20, 2018

最高経営責任者「CEO」Mr. Jeffrey N. (Jeff) Simmons

役員一覧

会社名

会社名/ポジション

ポジション

株式保有

変動額

Mr. Jeffrey N. (Jeff) Simmons

President, Chief Executive Officer, Director

2.36M

+36.70%

Mr. David Kinard

Executive Vice President - Human Resources, Corporate Communications and Administration

205.68K

+7.83%

Mr. Lawrence Erik Kurzius

Independent Chairman of the Board

150.03K

+26.80%

Mr. Michael J. Harrington

Independent Director

99.26K

--

Mr. Art A. Garcia, CPA

Independent Director

80.96K

--

Mr. Timothy J. (Tim) Bettington

Executive Vice President - Corporate Strategy and Market Development

80.40K

-22.66%

Dr. Deborah Turner Kochevar, Ph.D.

Independent Director

79.40K

--

Mr. Paul S. Herendeen

Independent Director

74.50K

--

Mr. James Meer

Senior Vice President, Chief Accounting Officer

62.55K

-1.82%

Ms. Shiv O'Neill

Executive Vice President, General Counsel, Corporate Secretary

53.92K

+100.82%

詳細を見る

会社名

会社名/ポジション

ポジション

株式保有

変動額

Mr. Jeffrey N. (Jeff) Simmons

President, Chief Executive Officer, Director

2.36M

+36.70%

Mr. David Kinard

Executive Vice President - Human Resources, Corporate Communications and Administration

205.68K

+7.83%

Mr. Lawrence Erik Kurzius

Independent Chairman of the Board

150.03K

+26.80%

Mr. Michael J. Harrington

Independent Director

99.26K

--

Mr. Art A. Garcia, CPA

Independent Director

80.96K

--

Mr. Timothy J. (Tim) Bettington

Executive Vice President - Corporate Strategy and Market Development

80.40K

-22.66%

収益内訳

通貨: USD更新時刻: Sun, Jul 6

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

事業別USD

会社名

収益

比率

Pet Health

635.00M

53.23%

Farm Animal

546.00M

45.77%

Contract Manufacturing

12.00M

1.01%

地域別USD

会社名

収益

比率

International

639.00M

53.56%

United States

554.00M

46.44%

事業別

地域別

事業別USD

会社名

収益

比率

Pet Health

635.00M

53.23%

Farm Animal

546.00M

45.77%

Contract Manufacturing

12.00M

1.01%

株主

更新時刻: Sat, Aug 16

株主統計

種類

株主統計

比率

Dodge & Cox

16.69%

PRIMECAP Management Company

10.42%

Fidelity Management & Research Company LLC

9.71%

The Vanguard Group, Inc.

9.59%

Dimensional Fund Advisors, L.P.

4.58%

他の

49.02%

株主統計

比率

Dodge & Cox

16.69%

PRIMECAP Management Company

10.42%

Fidelity Management & Research Company LLC

9.71%

The Vanguard Group, Inc.

9.59%

Dimensional Fund Advisors, L.P.

4.58%

他の

49.02%

種類

株主統計

比率

Investment Advisor

65.25%

Investment Advisor/Hedge Fund

33.54%

Hedge Fund

7.73%

Research Firm

1.85%

Individual Investor

1.08%

Pension Fund

0.74%

Bank and Trust

0.47%

Sovereign Wealth Fund

0.18%

Family Office

0.12%

機関投資家保有株

更新時刻: Tue, Jul 1

報告期間

機関投資家数

保有株式数

比率

変動額

2025Q2

882

515.44M

103.78%

-40.64M

2025Q1

974

511.32M

102.96%

-71.50M

2024Q4

996

503.77M

101.85%

-80.73M

2024Q3

1000

494.48M

100.04%

-96.31M

2024Q2

1034

494.94M

100.16%

-92.98M

2024Q1

1051

494.01M

100.22%

-99.13M

2023Q4

1048

492.96M

100.04%

-103.67M

2023Q3

1055

493.54M

100.18%

-93.98M

2023Q2

1067

490.17M

99.54%

-75.35M

2023Q1

1071

498.03M

101.25%

-46.19M

詳細を見る

株主動向

会社名

保有株式数

比率

変動額

変動率

日付

Dodge & Cox

82.92M

16.7%

-260.08K

-0.31%

Mar 31, 2025

PRIMECAP Management Company

50.22M

10.11%

-941.63K

-1.84%

Mar 31, 2025

Fidelity Management & Research Company LLC

38.30M

7.71%

+9.79M

+34.35%

Mar 31, 2025

The Vanguard Group, Inc.

48.14M

9.69%

-437.73K

-0.90%

Mar 31, 2025

Dimensional Fund Advisors, L.P.

20.46M

4.12%

+2.56M

+14.32%

Mar 31, 2025

BlackRock Institutional Trust Company, N.A.

20.06M

4.04%

-618.85K

-2.99%

Mar 31, 2025

T. Rowe Price Investment Management, Inc.

15.98M

3.22%

+292.65K

+1.87%

Mar 31, 2025

Black Creek Investment Management, Inc.

22.04M

4.44%

+1.61M

+7.87%

Mar 31, 2025

Fidelity Institutional Asset Management

15.55M

3.13%

+3.83M

+32.70%

Mar 31, 2025

Citadel Advisors LLC

6.87M

1.38%

+5.25M

+325.51%

Mar 31, 2025

詳細を見る

19.200USD

Elanco Animal Health Inc

19.200

概要

企業名

金融

分析